Sanders Profiled in DCA Live About Navigating the Life and Work During the COVID-19 Pandemic
25 March 2020
DCA Live
Partner David Sanders discussed with DCA Live founder and CEO Doug Anderson how he is navigating working remotely and family life during the COVID-19 Pandemic.
Sanders said he sees several new opportunities and ventures that might be created out of the health crisis including a greater acceptance of telehealth platforms, a permanent bump for life sciences companies and a permanent increase in the use of online learning platforms and video communication platforms.
Sanders told Anderson that several things are helping him maintain morale and productivity through this crisis, including “Weekly group calls; Foley’s Daily News featuring tips on remote working and occasional comic relief regarding the current situation; calls with team members at least every other day to maintain personal contact and physical activity.”
And the one thing he is looking forward to once it’s safe to resume normal life? Playing ice hockey
DCA Live hosts events that engage the people and companies that are driving growth in the Washington, D.C. economy and counts over 12,000 business professionals as members since it was created in 2014.
The entire profile was shared on Anderson’s LinkedIn.
People
Related News
13 December 2024
In the News
Brian Tomkins Featured Across Legal Press for Arrival to Foley
Foley & Lardner LLP partner Brian Tomkins is featured across legal press for his recent arrival to the firm.
11 December 2024
In the News
Nathan Beaver Discusses GLP-1 Compounding, FDA Deliberations
Foley & Lardner LLP partner Nathan Beaver discussed the ongoing deliberations at the U.S. Food and Drug Administration over a popular class of drugs in the PharmaVoice article, "GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?"
11 December 2024
In the News
Brian Wheeler Quoted on Dealmaking in GP-led Secondaries Market
Foley & Lardner LLP partner Brian Wheeler commented in the Pitchbook article, "GP-led secondaries to end 2024 with new record," assessing the prospects for dealmaking in the space heading into 2025.